A groundbreaking clinical trial shows that nine weeks of pembrolizumab treatment leaves bowel cancer patients cancer-free for nearly three years.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years
Nearly 3 Years duration Cancer-free duration
9 Weeks duration Preoperative treatment
Stage 2 And 3 classification Cancer stages treated
Pembrolizumab immunotherapy Treatment drug